HIV treatment and prevention 2019: current standards of care

N Phanuphak, RM Gulick - Current Opinion in HIV and AIDS, 2020 - journals.lww.com
HIV treatment and prevention 2019: current standards of care : Current Opinion in HIV and
AIDS HIV treatment and prevention 2019: current standards of care : Current Opinion in HIV …

[HTML][HTML] Why do people living with HIV not initiate treatment? A systematic review of qualitative evidence from low-and middle-income countries

S Ahmed, J Autrey, IT Katz, MP Fox, S Rosen… - Social science & …, 2018 - Elsevier
Background Many people living with HIV (PLWH) who are eligible for antiretroviral therapy
(ART) do not initiate treatment, leading to excess morbidity, mortality, and viral transmission …

Primary care guidance for persons with human immunodeficiency virus: 2020 update by the HIV Medicine Association of the Infectious Diseases Society of America

MA Thompson, MA Horberg, AL Agwu… - Clinical infectious …, 2021 - academic.oup.com
Advances in antiretroviral therapy (ART) have made it possible for persons with human
immunodeficiency virus (HIV) to live a near expected life span, without progressing to AIDS …

Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society–USA Panel

MS Saag, CA Benson, RT Gandhi, JF Hoy… - Jama, 2018 - jamanetwork.com
Importance Antiretroviral therapy (ART) is the cornerstone of prevention and management of
HIV infection. Objective To evaluate new data and treatments and incorporate this …

Benefits and risks of rapid initiation of antiretroviral therapy

N Ford, C Migone, A Calmy, B Kerschberger, S Kanters… - Aids, 2018 - journals.lww.com
Background: Recent attention has focused on the question of how quickly antiretroviral
therapy (ART) should be started once HIV diagnosis is confirmed. We assessed whether …

Effect of offering same-day ART vs usual health facility referral during home-based HIV testing on linkage to care and viral suppression among adults with HIV in …

ND Labhardt, I Ringera, TI Lejone, T Klimkait… - Jama, 2018 - jamanetwork.com
Importance Home-based HIV testing is a frequently used strategy to increase awareness of
HIV status in sub-Saharan Africa. However, with referral to health facilities, less than half of …

Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 …

HJ Stellbrink, JR Arribas, JL Stephens, H Albrecht… - The lancet HIV, 2019 - thelancet.com
Background The single-tablet regimen consisting of bictegravir, emtricitabine, and tenofovir
alafenamide is recommended for treatment of HIV-1 infection on the basis of data from 48 …

RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population

S Coffey, P Bacchetti, D Sachdev, O Bacon, D Jones… - Aids, 2019 - journals.lww.com
Objective: Little is known about long-term viral suppression rates for patients who start
antiretroviral therapy (ART) soon after diagnosis. We describe virologic outcomes from the …

Rapid initiation of antiretroviral therapy at HIV diagnosis: definition, process, knowledge gaps

MA Boyd, M Boffito, A Castagna, V Estrada - HIV medicine, 2019 - Wiley Online Library
Initiating antiretroviral therapy (ART) as early as the day of HIV diagnosis is a strategy of
increasing global interest to control the HIV epidemic and optimize the health of people …

Which community-based HIV initiatives are effective in achieving UNAIDS 90-90-90 targets? A systematic review and meta-analysis of evidence (2007-2018)

S Dave, T Peter, C Fogarty, N Karatzas, N Belinsky… - PloS one, 2019 - journals.plos.org
Background Reaching the Joint United Nations Programme on HIV/AIDS (UNAIDS) 90-90-
90 targets to end the HIV epidemic relies on effective interventions that engage untested …